Current Protein Identity:P80424 New Search
Main Difference Dimensions in This Set
Different construct Different mutation/modification Different assembly state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics

Difference tags compare only the current result set; every original PDB and assembly record remains separate.

Related-Structure Differences

Each row represents one biological assembly in one PDB entry; multiple monomers of the same protein are listed separately.

PDB Entry Assembly / Oligomeric State Construct Mutations and Modifications Ligands, Ions and Non-polymers Experimental Method Experimental Conditions Structure Quality
1AN1 LEECH-DERIVED TRYPTASE INHIBITOR/TRYPSIN COMPLEX Deposited 1997-06-26 Assembly 1 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain I 1–46(46 aa)
Mutation:N115D (D-ASPARTIC ACID FORM) CA CALCIUM ION × 1 X-RAY DIFFRACTION
X-ray crystallization conditions pH 8.5;30% V/V 2-PROPANOL, 0.2M AMMONIUM ACETATE, 0.1M TRIS-HCL, PH 8.5 ROOM TEMPERATURE 27 MONTHS FOR GROWTH.
Resolution 2.03 Å R-free 0.228
1LDT COMPLEX OF LEECH-DERIVED TRYPTASE INHIBITOR WITH PORCINE TRYPSIN Deposited 1997-05-15 Assembly 1 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain L 1–46(46 aa)
Not recorded CA CALCIUM ION × 1 X-RAY DIFFRACTION
X-ray crystallization conditions pH 8;10% PEG 6000, 2.3M PHOSPHATE, PH 8.0
Resolution 1.90 Å
2KMO Solution structure of native Leech-derived tryptase inhibitor, LDTI Deposited 2009-08-03 Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 1–44(44 aa) Fragment:residues 1-44
Not recorded No recorded non-water small molecule SOLUTION NMR
NMR measurement conditions pH 1.7;298 K;Pressure ambient
NMR sample composition 1.7 mM LDTI, 90% H2O/10% D2O | 90% H2O/10% D2O
NMR sample composition 1.7 mM LDTI, 100% D2O | 100% D2O
Resolution not provided
2KMP Solution structure of intermeidate IIa of Leeck-derived tryptase inhibitor, LDTI. Deposited 2009-08-03 Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 1–44(44 aa) Fragment:residues 1-44
Not recorded No recorded non-water small molecule SOLUTION NMR
NMR measurement conditions pH 1.7;298 K;Pressure ambient
NMR sample composition 1.7 mM LDTI, 90% H2O/10% D2O | 90% H2O/10% D2O
NMR sample composition 1.7 mM LDTI, 100% D2O | 100% D2O
Resolution not provided
2KMQ Solution structure of intermediate IIb of Leech-derived tryptase inhibitor, LDTI. Deposited 2009-08-03 Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 1–44(44 aa) Fragment:residues 1-44
Not recorded No recorded non-water small molecule SOLUTION NMR
NMR measurement conditions pH 1.7;298 K;Pressure ambient
NMR sample composition 1.7 mM LDTI-IIb, 90% H2O/10% D2O | 90% H2O/10% D2O
NMR sample composition 1.7 mM LDTI-IIb, 100% D2O | 100% D2O
Resolution not provided
2KMR Solution structure of intermediate IIc of Leech-derived tryptase inhibitor, LDTI. Deposited 2009-08-03 Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 1–44(44 aa) Fragment:residues 1-44
Not recorded No recorded non-water small molecule SOLUTION NMR
NMR measurement conditions pH 1.7;298 K;Pressure ambient
NMR sample composition 1.7 mM LDTI-IIc, 90% H2O/10% D2O | 90% H2O/10% D2O
NMR sample composition 1.7 mM LDTI-IIc, 100% D2O | 100% D2O
Resolution not provided